THEOBALD THERAPEUTICS LLC
THEOBALD THERAPEUTICS LLC
Industry:
Biotechnology Therapeutics
Founded:
2009-01-01
Website Url:
http://www.magnatherapeutics.com
Status:
Closed
Technology used in webpage:
SPF Amazon Amazon Virginia Region NameBright
Current Advisors List
Official Site Inspections
http://www.magnatherapeutics.com
- Host name: ec2-3-18-7-81.us-east-2.compute.amazonaws.com
- IP address: 3.18.7.81
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
More informations about "Theobald Therapeutics LLC"
Makana Therapeutics - Delivering Hope for the Future of …
Founded in 2009, Makana Therapeutics is focused on developing pigs with reduced xenoantigen expression, making human transplantation of cells, tissues and organs from these animals …See details»
Days after halting leukemia drug, Magenta moves to …
Feb 2, 2023 · A week after pausing a leukemia trial due to the death of a patient, Magenta Therapeutics is halting development of all its programs and exploring a potential sale or other measures to wind...See details»
Magenta Therapeutics - Crunchbase Company Profile …
Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology. View contacts for Magenta Therapeutics to access new leads and connect with decision-makers.See details»
Magenta Therapeutics - LinkedIn
Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of stem cell transplant to more patients with blood cancers, genetic diseases...See details»
Leadership & Governance - Magna
Oct 29, 2024 · Our operations span five continents and 28 countries, giving us a global footprint to support every major automaker in the world. Learn more about Magna's corporate governance …See details»
Magenta Therapeutics Announces Completion of Merger with
CAMBRIDGE, Mass., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Magenta Therapeutics, Inc. (Nasdaq: MGTA) (“Magenta”) today announced completion of the merger with Dianthus …See details»
Magenta Therapeutics to shut down after patient death
Feb 3, 2023 · Magenta Therapeutics Inc. is set to become at least the 10th Massachusetts biotech company to shut down since the start of 2022, following the death of a patient in a clinical trial. Magenta...See details»
Theobald Therapeutics LLC - Crunchbase Company Profile
Jun 11, 2020 · Who are Theobald Therapeutics LLC 's competitors? Alternatives and possible competitors to Theobald Therapeutics LLC may include Vaxira and NXT Biologics.See details»
Magenta Therapeutics to Explore Strategic Alternatives - Yahoo …
Feb 2, 2023 · Magenta has made the determination to halt further development of its programs and conduct a comprehensive review of strategic alternatives focused on maximizing …See details»
Magenta Therapeutics Announces IND Clearance for …
Sep 15, 2021 · Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of stem cell transplants to more patients with blood cancers, genetic diseases...See details»
Magenta to explore sale, merger after study setback
Feb 3, 2023 · Magenta Therapeutics is exploring a potential sale or merger as part of a business review it announced Thursday. The news comes one week after Magenta disclosed a patient …See details»
Magenta Therapeutics Appoints David Nichols as Chief Technical …
Apr 19, 2021 · CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the …See details»
Magenta Therapeutics Announces $86.4 Million Common Stock …
May 12, 2021 · Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of stem cell transplant to more patients with blood …See details»
Magenta Therapeutics Presents Positive MGTA-117 Clinical
Dec 12, 2022 · MGTA-117 is Magenta’s most advanced targeted conditioning product candidate designed to deplete CD117-expressing target cells in the blood and/or bone marrow prior to a …See details»
NIH, FDA and 15 private organizations join forces to increase …
The National Institutes of Health, U.S. Food and Drug Administration, 10 pharmaceutical companies and five non-profit organizations have partnered to accelerate development of …See details»
Magna Pharmaceuticals - Crunchbase Company Profile & Funding
MAGNA Pharmaceuticals is a pharmaceutical company that specializes in high-quality pharmaceutical products and optimize the overall health by bringing unique products that are …See details»
Magna Pharmaceuticals - Craft
It has two product divisions, consumer and prescription. The company focuses on allergy, cough and cold products and dietary supplements. See insights on Magna Pharmaceuticals including …See details»
OmniaBio Announces Opening of New Commercial Manufacturing …
Oct 17, 2024 · In partnership with the Centre for Commercialization of Regenerative Medicine (CCRM), MEDIPOST has established Omniabio, a cell and gene therapy contract …See details»
The 60-year-old startup: How Magna stays agile in a fast-changing ...
Jul 1, 2021 · “ “We're a $40 billion company and we are still a startup. Because we are in a $3 trillion industry and it's changing. And every time there is change, there is opportunity.” Swamy …See details»
Mana Therapeutics - Crunchbase Company Profile & Funding
View contacts for Mana Therapeutics to access new leads and connect with decision-makers. Where is Mana Therapeutics's headquarters? Mana Therapeutics is located in Arlington, …See details»